Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings
Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form of autoinjector (pen-injector device) in outpatient facilities compared with its use in the form of a syringe in hospital settings for the treatment of severe asthma (SA).Material and methods. The cost minimi...
Saved in:
| Main Authors: | M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-07-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/692 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Benralizumab in Reducing FeNO in Severe Eosinophilic Asthma: The Role of CRSwNP
by: Garcia-Rivero JL, et al.
Published: (2025-05-01) -
Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma
by: S. V. Nedogoda, et al.
Published: (2024-02-01) -
Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-08-01) -
Out of Breath, out of Options: Benralizumab as a Last Hope in ICU‐Treated Near‐Fatal Eosinophilic Asthma: A Case Series
by: Lennart Conemans, et al.
Published: (2025-03-01) -
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
by: Luisa Brussino, et al.
Published: (2025-03-01)